Advertisement
Home »

Meaningful Change Thresholds and Fatigue Severity Points on Patient reported Outcomes by the Fatigue Symptoms and Impacts Questionnaire (FSIQ-RMS) in Patients with Relapsing Multiple Sclerosis.

Feb 26, 2024

ABOUT THE EXPERTS

  • Stacie Hudgens

    Clinical Outcomes Solutions, Tucson, AZ, USA. Electronic address: stacie.hudgens@clinoutsolutions.com.

    Eva G Katz

    Janssen Research & Development, LLC, Raritan, NJ, USA.

    Evan Davies

    Actelion Pharmaceuticals Ltd, a Janssen pharmaceutical company of Johnson & Johnson, Allschwil, CH former employee when work was conducted.

    Alexander Keenan

    Janssen Pharmaceuticals, LLC, Pennington, NJ, USA.

    Tatiana Sidorenko

    Actelion Pharmaceuticals Ltd, a Janssen pharmaceutical company of Johnson & Johnson, Allschwil, CH.

    Carol Jamieson

    Janssen Research & Development, LLC, Milpitas, CA USA.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement